The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder (2014)
- Authors:
- USP affiliated authors: MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME
- Unidades: FM; IME
- DOI: 10.1016/j.tiv.2014.02.011
- Subjects: ANOREXIA; COMORBIDADE; TRANSTORNO OBSESSIVO-COMPULSIVO; PSICOFARMACOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Thousand Oaks
- Date published: 2014
- Source:
- Título: Journal of Psychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: V. 28, n. 6, p. 603-611, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc-nd
-
ABNT
DINIZ, Juliana B. et al. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, n. 6, p. 603-611, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2014.02.011. Acesso em: 29 dez. 2025. -
APA
Diniz, J. B., Costa, D. L. C., Cassab, R. C. C., Pereira, C. A. B., Miguel, E. C., & Shavitt, R. G. (2014). The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, ( 6), 603-611. doi:10.1016/j.tiv.2014.02.011 -
NLM
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011 -
Vancouver
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011 - Notice of Retraction and Replacement. Lopes et al. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized [Carta]
- Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder
- Association study between the-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder
- Quetotaxia dorsal e tagmatização em actinotrichida (Acariformes)
- Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder
- Adaptive treatment strategies for children and adolescents with obsessive-compulsive disorder: a sequential multiple assignment randomized trial
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
Informações sobre o DOI: 10.1016/j.tiv.2014.02.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
